CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Vnitř. Lék., 47, 2001, No. 9, p. 627-633
 
New Agents in the Treatment with Peroral Antidiabetics 
Pospíšilová Y.: 

Interní hematoonkologická klinika FN Brno, pracoviště Bohunice, přednosta prof. MUDr. J. Vorlíček, CSc.
 


Summary:

       In this article two new peroral antidiabetics are introduced. The first is repaglinide, a prandial glucose regulator. The second is rosiglitazone, a member of the thiazolidinediones family, which improves the sensitivity of tissues to insulin and reduces insulin resistance.

        Key words: Repaglinide - Thiazolidinediones - Rosiglitazone
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER